Absci Corp. (ABSI)
3.58
+0.19
(+5.60%)
USD |
NASDAQ |
Dec 16, 14:57
Absci Research and Development Expense (Annual): 63.86M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| CorMedix, Inc. | 3.942M |
| Verastem, Inc. | 81.33M |
| Fortress Biotech, Inc. | 56.88M |
| Anavex Life Sciences Corp. | 37.59M |
| Ocugen, Inc. | 30.16M |